Skip to main content

$0.180 0.015 (9.09%)

High

$0.18

Low

$0.17

Trades

42

Turnover

$91,156

Volume

530,592
30 June 2023 at 3:58pm
Register to track NUH and receive email alerts.

Nuheara Receives Ethics Approval To Commence Clinical Trial

StockBot

416,823 posts

NUH released this announcement to the ASX on 15 September 2021, 8:51. The announcement is marked as price sensitive, and is 2 page(s) in length and 265.2kb in size.

You can view all announcements from NUH and see how they appear on a price chart on the announcements page.

At the date of this announcement, NUH was 0.418% short sold according to ASIC data. It was ranked the 287th most shorted stock on the ASX. It remains ranked 555th as of the latest reported data (28 February 2025).

Other Recent Announcements from NUH
Change in substantial holding 29 June 2023, 16:03
Change in substantial holding 20 June 2023, 9:08
Letter to Shareholders - Notice of General Meeting 16 June 2023, 16:21
Nuheara Receives Ethics Approval To Commence Clinical Trial 15 September 2021, 8:51
Letter to Shareholders - Notice of Annual General Meeting 10 September 2021, 8:41
Notice of Annual General Meeting/Proxy Form 10 September 2021, 8:39
Notification of cessation of securities - NUH 2 September 2021, 19:10
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track NUH and receive email alerts.